I am known to some here as Mr. Sensitivity. I used to post

New Post Public Reply Private Reply Replies (1) Message Board
podcast WinnerTakeAll #7806
623
I am known to some here as Mr. Sensitivity. I used to post widely on Investors Hub until the threats and bashing got out of control. Several people from this message board asked me to write a report about the Federal Circuit Court hearing last Wednesday. This is volume 1 of 2.

I have followed the battles between DECN and J&J for 8 years. I did not start out being an expert in glucose sensor devices, but I believe I am now. When DECN was sued by J&J in 2011 for patent infringement, and then later for Trade Dress violations, I at first thought that J&J was employing overkill. At that point I did not know Mr. Berman, but have met him since. I asked myself why would a $170 billion corporation with a price setting oligopolistic position in a vital sector, want to put that position at risk by trying to crush a company that had no money, no viable product (at that point), and was burdened with, unfortunately, a partner who added nothing to the equation. It seemed to me leaving well enough alone was the better path to take. That is not what happened.


The first case in Federal District Court, the Federal Circuit Court and then again in the Federal District Court pointed out some very interesting things to investigate, such as, why had J&J not followed up on its technology with new technology in an effort to protect market share. The answer was, they tried and failed, multiple times. My next question was, if J&J was unable to develop new technology why did they not acquire a company that could help them. The answer to that was, they tried and failed. J&J had a terrible merger/acquisition profile. They would acquire a company and even before the ink was dry, they would fire the people involved at the target company. So, in what turned out to be a very insular industry, J&J had earned a terrible reputation. That in turn answered my questions about their virulent treatment of DECN. J&J knew that their Lifescan division was on a downward slope and by attacking DECN it would send a message to the industry that they were not to be messed with by big or smaller companies. This as it turns out was the first of a big series of mistakes.


The first litigations with J&J ended when DECN decided it was better for all that the Defendant DECN accept an olive branch and some money. However, as talks of a settlement progressed, DECN acquired two patents, using J&J money, and then sued J&J for patent infringement. That is the case that was further adjudicated in the Appeals Court last Wednesday. DECN also filed what is called an IPR and crushed J&J’s main test strip patent. That was a big win. So as the DECN patent infringement case progresses J&J is left without any real viable defenses --- a few technicalities they can exploit, a few good lies they can use, but all in all a nothingburger. The presentation by J&J’s counsel last Wednesday was wilted lettuce on that nothingburger, a presentation totally void of passion, emotion or desire. Will this feeble performance in front of the highest court that hears patent matters carry the day in DECN’s favor?


Perhaps, because it seems that the judges assigned to hear the case were not acquainted with either the arguments or the technology, but I think that DECN’s counsel did a brilliant job in educating the judges, especially given he was only was allowed 15 minutes to make his lasting impression. I believe he succeeded. I noticed this morning that one of the four cases heard last Wednesday has already been Rule 36ed. I thought that was a terrible case to bring in the first place involving old, old VCR technology and some Mickey Mouse remote control software. This was not lost on the judges. I also think that the fourth of four cases will be Rule 36ed too, perhaps as early as Monday morning. I believe strongly that DECN’s case will survive the cut, primarily due to the tactics employed by DECN’s counsel, where he educated the judges instead of preaching at them.


This will be the first of two postings I will make today. I will close this one by saying that based on J&J’s performance, they were convinced that they would win. This is a high court. Not being prepared is very arrogant. So, if a week or 10 days goes by and DECN is not Rule 36ed, which means their claims are not thrown out by the judges sans a review and ruling, the entire complexion of the case will change. J&J, in my opinion will not want to take this case to trial. The publicity will be terrible. Already Law360 should be asking both sides for interviews. And with that I will follow up after lunch with my conclusions.

Decision Diagnostics Corp (DECN) Stock Research Links

DECN Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

XMax's $30M Repurchase: Strategic Value Move

Updated Category News Views 57

XMax Enters Share Repurchase Game Who doesn’t love a buyback announcement from a company trying to put some faith back in its stock? XMax Inc., a name juggling the dual act of AI innovation and contemporary furniture dealings, just dropped a $30 million share repurchase bombshell. The firm aims to scoop up shares priced under $5.50, signifying it might think the...

Continue Reading
HikTech Star Tour Highlights Co-Innovation at Hikvision

Updated Category News Views 73

Innovation Meets Collaboration at HikTech Star Tour Ever been to one of those tech expos that's more about hype than substance? No smoke and mirrors here. The 2026 HikTech Star Tour wasn’t your run-of-the-mill tech meet-up. Held in Hangzhou, the event brought together 130 tech professionals from 56 countries. It’s like a digital United Nations, but with fewer speeches...

Continue Reading
New CEO at Armor: Nicholas Lee Takes Helm

Updated Category News Views 75

Leadership Shakeup at Armor Well, here's a twist in the ever-spinning merry-go-round of tech leadership: Armor's got a new top dog. Nicholas Lee, the former big shot at Fujitsu Intelligence, is now steering the ship as CEO, effective November 2, 2026. With his broad and varied playbook in tech and AI, Lee's stepping into some big shoes with plans to bolster Armor’s...

Continue Reading
Gutiérrez Honored with Enrique V. Iglesias Award

Updated Category News Views 85

Gutiérrez Recognized for Civic and Business Impact Alright, folks, here's a scenario to chew on: Dionisio Gutiérrez, a name that's likely resonated in business and civic corridors for a while, is about to add another feather to his cap. This November 4, Gutiérrez will bask in the limelight as King Felipe VI of Spain hands him the 11th Enrique V. Iglesias Award. It's...

Continue Reading
MIAX Preps New Binary Options Amid SEC Filings

Updated Category News Views 50

MIAX's Strategic Move Towards Binary Options Ah, that's something that might just shake things up a bit. On November 3rd, 2026, MIAMI International Holdings (NYSE: MIAX) made the headlines by filing with the SEC to offer cash-settled binary index options. Now, if you're not new to the trading game, you know that anything involving SEC registration gets the blood pumping....

Continue Reading
Hidden Fences: A Smarter Choice for Pet Owners?

Updated Category News Views 14

The Case for Invisible Fences Man's best friend meets modern containment! Why are hidden fences gaining traction in households across Culpeper, VA, and beyond? Pet Containment Expert Lawrence Sowers spills some valuable insights into why so many are ditching traditional fences. Practical reasons abound, folks! Keeping the Yard Beautiful Who wants their landscaping ruined...

Continue Reading
Q-Ball Intelligence Launches Predictive Powerhouse

Updated Category News Views 22

Breaking Out in the Predictive AI Scene Q-Ball Intelligence doesn't just stroll onto the AI stage; they bulldoze in, backed by a beefy research legacy starting way back in 2007. Now, after 19 years marinating in the depths of predictive research—and putting some serious cash where their AI mouth is—they've officially launched as the new big thing in predictive...

Continue Reading
TETRA Hits High Mark with Robust Q3 Earnings Surge

Updated Category News Views 118

Financial Milestones and Market Insights Boy, if you're not watching TETRA Technologies (NYSE:TTI) right now, you're probably missing out on a real barnstormer of a financial report. The numbers are looking chalkboards-be-damned stellar! They’ve just notched their finest third quarter in a decade, bringing in revenues through the roof at $168 million—an impressive 10%...

Continue Reading
Summit Midstream Prepares for Q3 2026 Earnings Report

Updated Category News Views 96

Quarterly financials are the canary in the coal mine for any energy firm. Scrutinizing those numbers can be the difference between riding a bull market or nursing your wounds in a ditch. So, what's on tap for Summit Midstream Corporation (NYSE: SMC)? They've circled November 9, 2026, on the calendar for releasing their third quarter figures, just after the NYSE bell...

Continue Reading
Boston Scientific's SIMPLAAFY Trial Promises Post-Op Ease

Updated Category News Views 160

SIMPLAAFY Trial Makes Waves in Cardiac Care Alright, let's dig into the heart of the matter—pun fully intended. Boston Scientific (NYSE:BSX) just rolled out some head-turning results from their SIMPLAAFY study, which evaluates the WATCHMAN FLX™ Pro Left Atrial Appendage Closure Device. What’s so special, you ask? Well, it’s all about simplifying the post-surgery...

Continue Reading

Top 5 Most Recently Viewed Articles

Exploring Church & Dwight Co's Upcoming Earnings Trends

Updated Category News Views 260

A Deep Dive into Church & Dwight Co's Earnings Potential Church & Dwight Co (NYSE: CHD) is gearing up to reveal its quarterly earnings report. Investors are keenly awaiting insights that could impact the company's future outlook and stock performance. Analysts forecast an earnings per share (EPS) of $0.73, but many are hoping for even better results. Understanding Past...

Continue Reading
Aimco to Release Q3 2024 Earnings Results Soon

Updated Category News Views 197

Aimco to Announce Third Quarter Earnings Apartment Investment and Management Company, commonly known as Aimco (NYSE: AIV), is preparing to share its financial performance for the third quarter of 2024. The company will issue its earnings report after market closure on the scheduled date. This announcement marks a significant moment for investors and analysts watching...

Continue Reading
October 2025 Transport Statistics of AS Tallink Grupp

Updated Category News Views 133

Insights from AS Tallink Grupp's October Performance In October 2025, AS Tallink Grupp reported transporting 467,279 passengers, marking a notable 2.5% decline from October 2024. Alongside this, the volume of cargo units saw a significant downturn, decreasing by 10.2%, totaling 21,855 units. Additionally, passenger vehicles also dipped, with a reduction of 2.6%, bringing...

Continue Reading
Eupraxia Pharmaceuticals Shares Exciting Updates on EoE Trial

Updated Category News Views 287

Eupraxia Pharmaceuticals' Latest Trial Results for EP-104GI Eupraxia Pharmaceuticals Inc. (TSX: EPRX) has reported exciting news regarding its ongoing clinical trial for the treatment of eosinophilic esophagitis (EoE) with EP-104GI. This treatment aims to alleviate symptoms and improve the quality of life for patients suffering from this challenging condition. Highlights...

Continue Reading
Clarius Named in TIME's Top HealthTech 2026 Again

Updated Category News Views 31

When a company gets the nod from TIME two years in a row, you know they’re not just tinkering with gadgets—they’re changing the game. Clarius Mobile Health, with its cutting-edge wireless ultrasound tech, has cemented its place in TIME's World's Top HealthTech Companies of 2026. Last I checked, repeating this kind of recognition never comes easy in such a fiercely...

Continue Reading